---
figid: PMC5509881__TJP-595-4571-g001
figtitle: 'Angiogenesis during pregnancy: all routes lead to MAPKs'
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC5509881
filename: TJP-595-4571-g001.jpg
figlink: /pmc/articles/PMC5509881/figure/tjp12428-fig-0001/
number: F1
caption: VEGF, oestrogen and its metabolites via interaction with distinct receptors
  activate the MAPK pathways, leading to endothelial cell proliferation during pregnancy.
  VEGF‐A interacts with VEGFR‐2 to activate the Ras–MEK–ERK pathway to promote endothelial
  cell proliferation (Gualandi L & Claesson‐Welsh L. (2011). Signal transduction by
  vascular endothelial growth factor receptors. Biochem J 437, 169–183). The findings
  from the Magness laboratory suggest that this pathway is also utilized by 17‐β‐oestradiol
  (E2β), norepinephrine (NE), epinephrine (Epi), 2‐hydroxyoestradiol (2‐OHE2) and
  4‐hydroxyoestradiol (4‐OHE2) in uterine arterial endothelial cells. Exchange protein
  directly activated by cAMP (EPAC) probably links β2/β3 adrenergic receptors (ARs)
  to the Ras–MEK–Erk pathway (Borland G, Smith BO & Yarwood SJ. (2009). EPAC proteins
  transduce diverse cellular actions of cAMP. Br J Pharmacol 158, 70–86.). In addition,
  E2β, catecholestradiols and catecholamines also stimulate uterine arterial endothelial
  cell proliferation via activation of p38 mitogen‐activated protein kinase (p38)
  and c‐Jun N‐terminal kinases (JNK).
papertitle: 'Angiogenesis during pregnancy: all routes lead to MAPKs.'
reftext: Xiang‐Qun Hu, et al. J Physiol. 2017 Jul 15;595(14):4571-4572.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.943461
figid_alias: PMC5509881__F1
figtype: Figure
redirect_from: /figures/PMC5509881__F1
ndex: 1f960cf9-df01-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5509881__TJP-595-4571-g001.html
  '@type': Dataset
  description: VEGF, oestrogen and its metabolites via interaction with distinct receptors
    activate the MAPK pathways, leading to endothelial cell proliferation during pregnancy.
    VEGF‐A interacts with VEGFR‐2 to activate the Ras–MEK–ERK pathway to promote endothelial
    cell proliferation (Gualandi L & Claesson‐Welsh L. (2011). Signal transduction
    by vascular endothelial growth factor receptors. Biochem J 437, 169–183). The
    findings from the Magness laboratory suggest that this pathway is also utilized
    by 17‐β‐oestradiol (E2β), norepinephrine (NE), epinephrine (Epi), 2‐hydroxyoestradiol
    (2‐OHE2) and 4‐hydroxyoestradiol (4‐OHE2) in uterine arterial endothelial cells.
    Exchange protein directly activated by cAMP (EPAC) probably links β2/β3 adrenergic
    receptors (ARs) to the Ras–MEK–Erk pathway (Borland G, Smith BO & Yarwood SJ.
    (2009). EPAC proteins transduce diverse cellular actions of cAMP. Br J Pharmacol
    158, 70–86.). In addition, E2β, catecholestradiols and catecholamines also stimulate
    uterine arterial endothelial cell proliferation via activation of p38 mitogen‐activated
    protein kinase (p38) and c‐Jun N‐terminal kinases (JNK).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Ne
  - Pvf1
  - ATPsynbeta
  - Atpalpha
  - B-H2
  - B-H1
  - hh
  - .na.character
  - ac
  - Shc
  - Sos
  - Epac
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - ras
  - Ras64B
  - Ras85D
  - RpL38
  - Mekk1
  - Raf
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - lic
  - p38b
  - Nurf-38
  - Ebp
  - AIMP2
  - p38a
  - Hrb87F
  - p38c
  - bsk
  - ec
  - TFPI
  - VEGFA
  - ATP8A2
  - ADRB2
  - NR1H4
  - BFAR
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - XYLT2
  - SOS1
  - SOS2
  - RAPGEF3
  - RAPGEF4
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - KRAS
  - HRAS
  - NRAS
  - ESR2
  - DBT
  - MAP3K1
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - CRK
  - MAPK14
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK8
  - MAPK9
  - MAPK10
  - KDR
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
---
